Table 1.
Summary of Associations of SC and CV with HLA-class I, II and KIR.
Injection Drug Users (IDU) | Blood Transfusion | IDU and Blood Transfusion | Unknown | |||||
---|---|---|---|---|---|---|---|---|
HLA association | SC | CV | SC | CV | SC | CV | SC | CV |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
Reference (Ethnicity) |
|
HLA-DRB1*0101 | (Mangia, 1999; McKierman 2004, Fanning, 2000; McKierman 2000;Barret,1999) (C) | (Thio, 2001) (AA and C) | ||||||
HLA-DRB1*0104 | (Cramp, 1998) (C) | |||||||
HLA-DRB1*0301 | (McKierman 2004) (C) | (Thio, 2001) (C) | (Yenigun, 2002) (C) | |||||
HLA-DRB1*0401 | (McKierman 2000) (C) | (Cramp, 1998)(C) | ||||||
HLA-DRB1*0701 | (Thursz, 1999) (C) | |||||||
HLA-DRB1*1101 | Present report (H) (trend) | (Thursz, 1999) (C) | (Holer, 1997) (T) | |||||
HLA-DRB1*1201 | Present report (H) | |||||||
HLA-DRB1*1301 | (Holer, 1997) (C) | |||||||
HLA-DRB1*1501 | (Lechmann 1999) (C) | (Lechmann, 1999) (C) | ||||||
HLA-DQA1*0103 | (Holer, 1997) (C) | |||||||
HLA-DQA1*0201 | (Zavaglia, 1998) (C) | |||||||
HLA-DQA1*0301 | (Cramp, 1998) (C) | |||||||
HLA-DQA1*0801 | (Zavaglia 1998) (C) | |||||||
HLA-DQB1*0201 | (McKierman 2004) (C) | (Zavaglia, 1998) (C) | ||||||
HLA-DQB1*0301 | (Thio, 2001), (Cramp,1998) (AA and C) | |||||||
HLA-DQB1*0501 | (Azocar, 2003) (trend)(H) Present report (H) | (McKierman 2004) (C) | (Thio, 2001) (AA and C) | |||||
HLADRB1*1101/DQB1*0301 | (Yee, 2004) (C) | (Thursz, 1999; Alric, 1997; Minton 1998) (C) | ||||||
HLA-DRB1*1104/DQB1*0301 | (Mangia 1999)(C) | (Zavaglia, 1998) (C) | ||||||
HLA-DRB1*12 | ||||||||
HLA C1/C1/KIR 2DL3/2DL3 | (Khakoo, 2004)(AA); | (Khakoo, 2004) (C) | ||||||
HLA C1/C1/KIR2DL3/2DL3 + HLADRB1*1201 |
SC: Spontaneous Clearance; CV: Chronic Viremia; C: Caucasian; AA: African American; Hispanic;